Glucagon-Like Peptide-1 Receptor Agonist Semaglutide Improves Eating Behavior and Glycemic Control in Japanese Obese Type 2 Diabetic Patients

We evaluated time-course changes and the relationship between eating behavior and glycemic profile during the treatment of 34 obese type 2 diabetic patients with the glucagon-like peptide-1 receptor agonist (GLP1-RA) semaglutide. Changes in dietary habits were evaluated using the Japan Society for t...

Descripción completa

Detalles Bibliográficos
Autores principales: Masaki, Takayuki, Ozeki, Yoshinori, Yoshida, Yuichi, Okamoto, Mitsuhiro, Miyamoto, Shotaro, Gotoh, Koro, Shibata, Hirotaka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8878247/
https://www.ncbi.nlm.nih.gov/pubmed/35208221
http://dx.doi.org/10.3390/metabo12020147

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8878247/
https://www.ncbi.nlm.nih.gov/pubmed/35208221
http://dx.doi.org/10.3390/metabo12020147

Ejemplares similares